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The Short-Term Effects of Balloon-
Occluded Retrograde Transvenous
Obliteration, for Treating Gastric Variceal
Bleeding, on Portal Hypertensive
Changes: a CT Evaluation
Objective: We wanted to evaluate the short-term effects of balloon-occluded
retrograde transvenous obliteration (BRTO) for treating gastric variceal bleeding,
in terms of the portal hypertensive changes, by comparing CT scans.
Materials and Methods: We enrolled 27 patients who underwent BRTO for
gastric variceal bleeding and they had CT scans performed just before and after
BRTO. The pre- and post-procedural CT scans were retrospectively compared by
two radiologists working in consensus to evaluate the short-term effects of BRTO
on the subsequent portal hypertensive changes, including ascites, splenomegaly,
portosystemic collaterals (other than gastrorenal shunt), the gall bladder (GB)
edema and the intestinal wall edema. Statistical differences were analyzed using
the Wilcoxon signed rank test and the paired t-test.
Results: Following BRTO, ascites developed or was aggravated in 22 (82%) of
27 patients and it was improved in two patients; the median spleen volumes
increased from 438.2 cm
3 to 580.8 cm
3, and based on a 15% volume change cut-
off value, splenic enlargement occurred in 15 (56%) of the 27 patients. The devel-
opment of new collaterals or worsening of existing collaterals was not observed in
any patient. GB wall edema developed or was aggravated in four of 23 patients
and this disappeared or improved in five; intestinal wall edema developed or was
aggravated in nine of 27 patients, and this disappeared or improved in five.
Statistically, we found significant differences for ascites and the splenic volumes
before and after BRTO (p  = 0.001 and p  < 0.001, respectively).
Conclusion: Some portal hypertensive changes, including ascites and
splenomegaly, can be aggravated shortly after BRTO.
alloon-occluded retrograde transvenous obliteration (BRTO) is now
increasingly accepted as an effective treatment for gastric varix, and it is
indicated for those gastric varices with a major portosystemic shunt such
as a gastrorenal shunt or a shunt involving the left inferior phrenic vein (1 10). BRTO
has achieved an initial high rate of success (87 100%) and a low rate of relapse (0
10%) (5, 9, 11 13) because the sclerosant is injected directly into the gastric varix
through a draining vein, while at the same time, the variceal blood flow is stopped by
retrograde balloon occlusion.
Balloon-occluded retrograde transvenous obliteration has two main effects on the
portal hemodynamics due to its obliteration of the major portosystemic shunt (i.e.,
gastrorenal shunt); it increases the portal hepatic blood flow and elevates the portal
venous pressure (14 16). It is known that increasing the portal hepatic blood flow
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Bafter BRTO can improve liver function, indicating that
BRTO can be performed in patients with severe liver
dysfunction (15 17). On the other hand, elevation of
portal venous pressure after performing BRTO implies that
BRTO can aggravate a variety of portal hypertensive
changes, including ascites, splenomegaly, the development
of portosystemic collaterals and edema of the gall bladder
(GB) or the intestinal wall. It has been well established that
BRTO induces delayed or late worsening of esophageal
varices (8, 10, 11); however, the effects of BRTO on the
other portal hypertensive changes have not been
established.
Thus, we aimed to evaluate the short-term effects of
BRTO, which was performed to treat gastric variceal
bleeding, on the portal hypertensive changes. This was
done by comparing the CT scans that were obtained just
before and after the BRTO procedures.
MATERIALS AND METHODS
Subjects
Between December 2002 and November 2005, a total of
54 patients suffering with liver cirrhosis and portal
hypertension underwent BRTO procedures at our institu-
tion to treat their bleeding from gastric varices. This study
intended to evaluate the short-term effects of BRTO on
portal hypertensive changes; therefore, we excluded 24
patients who did not undergo CT scanning immediately
prior to BRTO, and for whom the presence of a gastrorenal
shunt had been already confirmed by previous CT
scanning. We also excluded one patient for whom BRTO
failed to completely eradicate the gastric varix. In addition,
we excluded two patients who had a factor that could have
potentially interfered with our analysis of the effects of
BRTO on portal hypertensive changes (a partial portal vein
thrombosis that existed before the procedure in one
patient and the other patient had previously undergone
transjugular intrahepatic portosystemic shunt). 27 patients
were finally enrolled in the study. Institutional review
board approval was obtained for the required retrospective
review of the patients’ records, but informed patient
consent was not required for this retrospective analysis.
There were 18 men and nine women (age range: 32 to
83 years, mean age: 56.3 years). BRTO was electively
performed in 19 patients following initial hemostasis for
gastric variceal bleeding and BRTO was performed on an
emergency basis in eight patients because of persistent
active bleeding or rebleeding after initial hemostasis. The
mean systolic blood pressure at the time of arrival to our
hospital was 113 mmHg (range: 60 164 mmHg). The
lowest systolic blood pressure and hemoglobin level
around the time of the pre-procedural CT scans ranged
from 54 to 127 mmHg (mean: 86 mmHg) and from 2.9 to
11.3 g/dL (mean: 7.6 g/dL), respectively. Transfusion of
red blood cells was required in 23 patients to maintain
their hemodynamic parameters such as the blood pressure,
pulse rate and hemoglobin levels. The endoscopically
defined gastric varix locations were the cardiofundal
region in 14 patients, the fundal region in 12 and the
cardiac region in one. Gastric varices were associated with
portal hypertension as a result of viral liver cirrhosis in 22
patients, alcoholic liver cirrhosis in four and liver cirrhosis
of an unknown cause in one. Six patients were of Child-
Pugh class A, 14 were of class B and seven were of class C.
Four patients had a history of previous cholecystectomy.
Ten patients had complicating hepatocellular carcinoma
with no tumor thrombosis in the portal vein.
BRTO Procedures
A written informed consent for the procedures was
obtained from all the patients or their responsible family
members. The pre-procedural CT scans were obtained
from three to 99 hours (mean: 41 hours, median: 36 hours)
prior to BRTO, and these confirmed the presence of a
gastrorenal shunt. BRTO was performed as previously
described (5, 6, 18). Briefly, a 7 9 Fr balloon catheter
with an 8.5 33 mm occlusion balloon (Boston Scientific,
Watertown, MA) was inserted in the gastrorenal shunt
through the right femoral vein (n = 26) or the internal
jugular vein (n = 1) under local anesthesia. After inflating
the balloon to stop the gastrorenal shunt blood flow,
retrograde venography was performed to identify the
gastric varices and their feeding and draining vessels. In 19
patients, microcoils, gelfoam or both were used to
embolize other blood-draining collaterals of the gastric
varices, such as the inferior phrenic and/or retroperitoneal
veins. A mixture of 5% ethanolamine oleate (Keuk Dong
Pharmaceuticals, Incheon, Korea) with contrast medium
(Ultravist 300, Schering AG, Berlin, Germany) or lipiodol
(Laboratories Guerbet, Aulnay-sous-Bois, France) (ratio =
4 5:1) was injected slowly and intermittently under
fluoroscopic control until a small amount of reflux into the
feeding vessels was observed following varix opacification.
The volume of the injected mixture ranged from 12 to 50
ml (mean: 30.7 ml). The balloon catheter was left in the
gastrorenal shunt for 3 29 hours at the discretion of the
treating interventional radiologist; this decision was based
on the shunt size, the timing of the procedure and the
platelet count. The balloon catheters were removed after
checking for the formation of stable thrombus via
fluoroscopy. Haptoglobin was not administered during the
procedure because this agent was not available on our
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of their gastric varices with thrombus formation was
confirmed on the post-procedural CT scans; these were
obtained within five to 150 hours postoperatively (mean:
58 hours, median: 51 hours). The interval between the pre-
and post-procedural CT scans ranged from 44 hours to 186
hours (mean: 99 hours, median: 86 hours). 
CT Imaging and Analysis
The CT examinations were performed using one of four
randomly selected CT scanners (Brilliance 40, Philips,
Eindhoven, Netherlands; LightSpeed QX/I, Lightspeed 16
or Lightspeed Ultra, GE Healthcare, Milwaukee, WI). The
helical CT images were obtained in a craniocaudal
direction from the top of the liver to the level of the lower
pole of the right kidney, with using a 2.5-mm to 5-mm
reconstruction interval and a 5-mm slice thickness. A total
of 120-mL of nonionic contrast material (Ultravist 300,
Schering AG, Berlin, Germany) was administered at a rate
of 3 mL/sec with using an automated power injector. The
images were obtained 30, 60 and 180 sec after initiating
intravenous injection of contrast medium; these images
represented the hepatic arterial, portal venous and equilib-
rium phases, respectively. The images taken during the
equilibrium phase were extended to the level of the pelvis
in the patients who had a spleen that extended below the
lower kidney pole. The images taken before contrast
medium injection were routinely available among the post-
procedural CT scans.
The pre- and post-procedural CT scans were retrospec-
tively compared by two radiologists working in consensus
with respect to the short-term effects of BRTO on the
following portal hypertensive changes; ascites,
splenomegaly, portosystemic collaterals other than the
gastrorenal shunt, GB edema and intestinal wall edema. In
addition, the follow-up CT scans obtained at least one
month after BRTO, if they were available, were also
compared to determine the serial changes of these
evaluated points.
For objective comparisons of ascites, the ascites’
thicknesses at eight points were measured and scored. The
bilateral ascites thicknesses were measured horizontally at
the mid antero-posterior portion to the abdominal wall on
the four axial CT image planes: the dome of the liver at the
level of the junction between the right hepatic vein and the
inferior vena cava, the middle of the liver at the level of
the portal bifurcation, the bottom of the liver and the
lower pole of the right kidney. The ascites’ thicknesses at
every point were scored from zero to 3 based on the value
that was measured as 0: no ascites, 1: ascites < 2.5 cm in
the distance, 2: ascites between 2.5 and 5 cm, 3: ascites > 5
cm) and then the scores were summed up. If a difference in
the total ascites score was found between the pre- and
post-procedural CT scans, then the ascites was regarded as
either aggravated or improved. 
The spleen volumes were calculated by the sum-of-areas
method (19, 20). At a workstation, the outline of the
spleen on each section of the axial CT scan was traced and
we computed the area that was enclosed. The splenic
volume in each section was obtained by multiplying the
area by the section thickness, and all the sections were
summed to determine the total splenic volume. The
uncertainty of the assigned volumes with using this method
was reported to be 3.6  4.5% (19); therefore, volume
changes > 15% (greater than 2 standard deviations) after
BRTO were considered to indicate real increases or
decreases (21). 
The presence of portosystemic collaterals other than the
gastrorenal shunt was evaluated in four locations, including
the gastroesophageal, paraumbilical, mesenteric and
retroperitoneal locations (22, 23). We considered that
there was the development of alternative collaterals when
a new collateral vessel  3 mm in the diameter was
detected, and there was worsening of alternate collaterals
when the diameter of an existing collateral vessel was
enlarged  2 mm. No evaluation of esophageal varix was
included in this study because our routine CT scans
covered only a limited part of the distal esophagus and we
considered endoscopy as the optimal method of evaluation
for esophageal varix.
GB edema was defined as diffuse wall thickening ( 4
mm) (24, 25). The maximum GB wall thicknesses were
measured, and aggravation or improvement was consid-
ered to have happened when a change of  2 mm was
noted in the wall thickness between the pre- and post-
procedural CT scans.
Intestinal wall edema was considered present when there
was diffuse wall thickening (> 6 mm in the colon, > 3 mm
in the small bowel) (26, 27). Because the CT images did
not include the pelvis, the anatomic distribution of the
bowel was divided into four segments: small bowel and the
ascending, transverse and descending colon. The number
of edematous bowel segments was recorded (no segment
to 4 segments). Intestinal wall edema aggravation/improve-
ment was defined as a change in the number of edematous
bowel segments on the pre- and post-procedural CT scans.
Laboratory findings such as serum albumin levels, red
blood cell (RBC), and platelet counts, which were checked
on the days of the pre- and post-procedural CT scans, were
also compared to reveal the association between other
factors such as hypoalbuminemia and the portal hyperten-
sive changes and to determine whether there was any
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and those without splenic enlargement after BRTO. 
The Wilcoxon signed ranks test was used to analyze
changes in the amounts of ascites, and the paired t-test was
used to analyze the changes in the splenic volumes, the GB
wall thicknesses and the number of edematous bowel
segments before and after BRTO. The Kruskal-Wallis test
was used to analyze the association between the changes in
the serum albumin levels and the portal hypertensive
changes before and after BRTO. The Mann-Whitney test
was used to analyze the difference in the changes of the
RBC and platelet counts between the patients with and
those without splenic enlargement after BRTO. All the
statistical analyses were performed with using a commer-
cially available software package (SPSS version 11.5;
SPSS, Chicago, IL). 
RESULTS
The detailed CT comparative results of the portal
hypertensive changes observed in the 27 patients are
presented in Table 1. Follow-up CT scans were available in
19 of 27 patients, and their comparative results are also
presented in Table 1. The time of follow-up CT examina-
tions ranged from one to 17 months after BRTO, with a
mean of 3.9 months (median: 2 months).
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Table 1. The Short-term Effects of Balloon-occluded Retrograde Transvenous Obliteration on the Five Portal Hypertensive
Changes: Comparative Results of the Pre-, Post-procedural and Follow-up CT Scans for the 27 Study Subjects
SBP 
Serum  Time of CT 
Changes of Each Point after BRTO
(mmHg)
Albumin Scans  from 







Hb Level  (RBC 
Pre Post  Pre  Post  FU  GB 
Intestinal 










1/M/67 B 86 78 8.0 17 3.4 2.6 77 23 14 D (CR) No (No) No (No) 31 (8) NC of Cv (A of Cv)
2/M/37 B 149 63 9.3 12 2.2 2.8 18 51 NA D CR I 120 No
3/M/72 A 155 98 9.5 4 2.9 2.7 17 44 1 D (CR) No (No) A (CR) 11 (19) NC of Cv (NC)
4/M/67 B 94 94 2.9 6 2.7 2.8 76 86 1 NC (I) No (No) No (No) -2 (2) No (No)
5/M/45 A 136 106 7.6 4 3.6 3.4 49 45 17 A (CR) No (No) CR (No) -1 (3) NC of Cv (NC of Cv and D of Uv)
6/M/52 C 100 85 8.3 9 2.5 2.7 42 24 9 A (I) NA (NA) NC (NC) 28 (28) No (No)
7/F/61 B 135 71 8.7 1 2.9 2.5 76 55 NA D A D 32 No
8/M/66 A 134 102 7.6 2 3.8 3.5 65 48 3 No (No) No (No) No (No) 13 (7) No (No)
9/M/32 C 120 84 3.1 8 2.8 3.2 49 15 NA D D D 19 No
10/M/48 A 114 92 8.5 0 3.5 3 25 41 1 D (A) No (D) No (D) 13 (4) No (No)
11/F/64 C 82 65 7.7 4 2.6 2.6 96 5 NA A A A -11 NC of Uv
12/F/60 B 148 84 7.9 5 2.3 2 4 40 6 A (CR) NA (NA) D (CR) 26 (41) No (No)
13/M/63 B 81 81 6.0 5 2.3 2 20 66 NA D D  D  22 NC of Cv and Uv
14/F/57 A 104 97 8.4 2 2.8 3.1 3 41 NA D NC No 1 No
15/F/46 B 106 91 8.6 3 2.9 3.7 44 218 NA I CR I  -9 NC  of  Cv
16/F/64 B 146 106 7.0 4 3.1 2.9 16 54 3 D (CR) NA (NA) I (CR) 21 (5) NC of Cv (NC)
17/M/52 C 97 97 5.8 6 2.2 2.2 24 54 NA A No A -5 No
18/M/41 B 99 65 9.5 4 2.8 2.9 48 72 4 D (CR) No (No) No (No) 0 (3) NC of Cv and Uv (A of Cv and NC of Uv)
19/M/46 A 164 97 8.9 0 3.2 3.2 72 97 1 D (CR) NC (NC) No (No) 24 (18) NC of Cv (NC)
20/M/70 C 80 80 7.8 4 2.1 2 40 74 1 I (CR) NA (NA) D (CR) 5 (-3) NC of Cv and Uv (NC)
21/F/69 C 60 60 7.4 4 1.9 2.6 5 79 2 A (NC) NC (NC) NC (CR) 59 (50) No (D of Uv)
22/F/83 B 76 76 4.3 17 1.9 2.5 80 60 4 A (CR) NC (CR) CR (No) 113 (120) NC of Uv (A of Uv)
23/M/59 B 101 101 8.9 0 2.7 2.2 13 51 2 No (No) No (No) No (No) 26 (49) No (No)
24/F/50 C 114 95 8.8 3 2.1 2.5 27 45 1 D (CR) I (A) No (No) 73 (71) NC of Uv (NC)
25/M/51 B 150 127 11.4 1 2.5 2.8 4 139 2 D (A) CR (No) No (D) 44 (0) No (D of Uv)
26/M/43 B 86 74 7.4 7 3 2.6 14 58 1 D (CR) I (CR) D (CR) 78 (91) NC of Uv (NC)
27/M/54 B 129 54 7.2 15 2.7 3.2 99 51 2 A (I) No (No) NC (CR) 1 (0) No (No)
Note. * Percent of changes in the splenic volume when compared to that on the pre-procedural CT scans, in which the minus symbol means a decrease 
in the volume. BRTO = Balloon-occluded Retrograde Transvenous Obliteration, SBP = systolic blood pressure, Hb = hemoglobin, TF = transfusion, RBC =
red blood cell, FU = follow-up, GB = gall bladder, NA = not available, Cv = coronary vein, Uv = umbilical vein, D = development, A = aggravation, I =
improvement, CR = complete resolution, NC = no change.Cho et al.
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Fig. 1. Patient 13. A 63-year-old man with liver cirrhosis who experienced worsening of his ascites, edemas of the GB and intestinal wall
and spleen enlargement after balloon-occluded retrograde transvenous obliteration. The serum albumin levels before and after balloon-
occluded retrograde transvenous obliteration were 2.3 g/dL and 2.0 g/dL, respectively. 
A, B. The pre- (A) and post-procedural (B) CT scans at the level of the dome of the liver, obtained 20 hours before balloon-occluded
retrograde transvenous obliteration and 66 hours after balloon-occluded retrograde transvenous obliteration, respectively, show the new
development of ascites (arrow). His total ascites score increased from zero to 6 after balloon-occluded retrograde transvenous obliteration.
C, D. The pre- (C) and post-procedural (D) CT scans at the GB level show the new development of GB edema after balloon-occluded
retrograde transvenous obliteration (arrows), in which the maximum GB wall thickness increased from 2 mm to 5 mm.
E, F. The pre- (E) and post-procedural (F) CT scans at the level of the right renal hilum show the new development of intestinal wall
edema involving the ascending, transverse and descending colon (arrows).
EFCT Evaluation of Balloon-Occluded Retrograde Transvenous Obliteration Effect for Gastric Variceal Bleeding Treatment
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Fig. 2. Patient 2. A 37-old-year man with liver cirrhosis who experienced the development of ascites and spleen enlargement, but also
improvement of his intestinal wall edema and his GB edema disappeared after balloon-occluded retrograde transvenous obliteration.
The serum albumin levels before and after balloon-occluded retrograde transvenous obliteration were 2.2 g/dL and 2.8 g/dL, respec-
tively.
A, B. Pre- (A) and post-procedural (B) CT scans at the level of the dome of the liver, obtained 18 hours before balloon-occluded
retrograde transvenous obliteration and 51 hours after balloon-occluded retrograde transvenous obliteration, respectively, show the
development of new bilateral ascites. His total ascites score increased from zero to 8 after balloon-occluded retrograde transvenous
obliteration.
C, D. The pre- (C) and post-procedural (D) CT scans at the GB level show that the GB edema has disappeared after balloon-occluded
retrograde transvenous obliteration (arrows), and there is a reduction in the maximum GB wall thickness from 10 mm to 2 mm.
E, F. Diffuse bowel wall thickening (> 6 mm) is evident in the ascending, transverse, and descending colon (arrows) on the pre-
procedural CT scans (E), but this is seen only in the ascending colon (arrowhead) on the post-procedural CT scans (F), which indicates
that the intestinal wall edema is much improved after balloon-occluded retrograde transvenous obliteration.
EFWith regard to ascites, the total ascites scores on pre- and
post-procedural CT scans ranged from 0 to 14 (median
score: 0) and from 0 to 15 (median score: 5), respectively.
Ascites developed or it was aggravated in 22 of 27 patients
(82%), this was improved in two (7%), and unchanged in
1 (4%) following BRTO (Figs. 1, 2). No development of
ascites after BRTO was observed in the other two patients
(7%). Thus, there was significant aggravation or the
development of ascites after BRTO (p = 0.001). For two
patients who displayed improvement of their ascites after
BRTO, the serum albumin level was elevated from 2.9
g/dL to 3.7 g/dL in one patient and it was reduced from 2.1
g/dL to 2.0 g/dL in the other. Follow-up CT scans were
available for 17 of the 25 patients who had ascites noted
on the post-procedural CT scans; on these scans, the ascites
disappeared or was improved in 14 patients (82%), it was
aggravated in two (12%), and it was unchanged in one
(6%). The other two patients had no ascites on both the
post-procedural and follow-up CT scans. 
The pre-procedural spleen volumes ranged from 119 cm
3
to 1,290 cm
3 with a median volume of 438.2 cm
3, and the
post-procedural spleen volumes ranged from 151 cm
3 to
1,306 cm
3 with a median volume of 580.8 cm
3. The median
change of the spleen volume was 21% with a range of 
11% to 120%. Based on a volume cut-off of 15%, the
spleens were enlarged in 15 of the 27 patients (56%) after
BRTO. Thus, the spleens were found to be significantly
enlarged after BRTO (p < 0.001) (Fig. 2). The mean values
standard deviations of the RBC and platelet counts
were 3.04  0.67 10
6/ l and 79.00  49.63 10
3/ l
before BRTO, respectively, and 3.33  0.43 10
6/ l and
57.8  29.13 10
3/ l after BRTO, respectively. There
were no statistical differences in the changes of the RBC
and platelet counts between the patients with and those
without splenic enlargement after BRTO (p = 0.329 for the
RBC count, p = 0.283 for the platelet count). The follow-
up CT scans were available for 11 of the 15 patients with
splenic enlargement after BRTO; this splenic enlargement
was static in eight (73%) of the 11 patients, but the volume
of the spleen returned to the baseline in the other three
patients. Eight of the other 12 patients with no splenic
enlargement after BRTO underwent follow-up CT scans;
new splenic enlargement was observed on the scans of one
patient.
The portosystemic collateral veins found on the pre-
procedural CT, other than a gastrorenal shunt, were
coronary (n = 6), umbilical (n = 4), or both (n = 3), and
none of them were enlarged ( 2 mm in diameter) on the
post-procedural CT scans. No development of new collat-
eral veins ( 3 mm in diameter) was observed on the post-
procedural CT scans. Coronary veins acting as feeder
veins, which were confirmed by obliteration of the veins
on post-procedural CT scans, were not viewed as the other
portosystemic collateral veins. On the follow-up CT scans
of 19 patients, six (32%) patients had developed new
collateral veins or there was worsening of the existing
collateral veins (development of the umbilical vein in two
patients and worsening of the existing coronary or umbili-
cal veins in the other 4 patients). 
The GB wall thicknesses observed on the pre- and post-
procedural CT scans ranged equally from 2 to 10 mm with
a median wall thickness of 3 mm (p = 0.418). GB edema
developed or was aggravated in four of 23 patients (Fig. 1)
and this disappeared or was improved in five patients after
BRTO (Fig. 2). The GB wall thickness was unchanged in 14
(61%) of 23 patients. The follow-up CT scans were
available for five of the 10 patients with GB edema seen
on the post-procedural CT scans; on these follow-up scans,
Cho et al.
526 Korean J Radiol 8(6), December 2007
Fig. 2. G, H. The pre- (G) and post-procedural (H) CT scans at the splenic hilum level show splenic enlargement after balloon-occluded
retrograde transvenous obliteration. A volume calculation indicated a 120% increase of the spleen volume.
GHthe GB edema disappeared in two patients, it was
unchanged in two and it was aggravated in one. Ten of the
other 13 patients with no GB edema seen on the post-
procedural CT had follow-up CT scans, on which GB
edema had developed in one patient. The other four
patients with follow-up CT scans had all undergone
previous cholecystectomy.
As for the intestinal wall edema, the number of
edematous bowel segments on the pre- and post-
procedural CT scans ranged equally from zero to 4, but
with medians of 0 and 1, respectively. However, no statis-
tical difference was found in terms of the number of
edematous bowel segments (p = 0.284). Intestinal wall
edema developed or was aggravated in nine of the 27
patients (33%) (Fig. 1) and this disappeared or was
improved in five patients (19%) after BRTO (Fig. 2). No
change in the number of edematous bowel segments was
observed in 13 patients (48%). Follow-up CT scans were
available for eight of the 15 patients with intestinal wall
edema seen on the post-procedural CT scans, on which the
intestinal wall edema disappeared in seven patients and it
was unchanged in one. Eleven of the other 12 patients with
no intestinal wall edema on the post-procedural CT had
follow-up CT scans done, on which intestinal wall edema
developed in two patients.
Aggravation of the four portal hypertensive changes,
including ascites, splenic enlargement and edemas of the
intestine and GB, was found in three of the 27 patients
after BRTO; one to three of these four portal hypertensive
changes developed or was aggravated in 13 of 27 patients
after BRTO and none of them was changed in two patients.
For other eight patients, some of the portal hypertensive
changes were aggravated, but the others were ameliorated
after BRTO. In one patient (patient 15), improvement of
ascites, GB edema and intestinal wall edema was observed
after BRTO. 
The mean values  standard deviations of the serum
albumin levels before and after BRTO were 2.72  0.51
g/dL (range, 1.9 3.8 g/dL) and 2.75  0.45 g/dL (range,
2.0 3.7 g/dL), respectively. There was no significant
association between the changes of the serum albumin
levels and the changes of the ascites (p = 0.502),
splenomegaly (p = 0.642), GB edema (p = 0.449), and
intestinal wall edema (p = 0.152) before and after BRTO. 
DISCUSSION
The risk of aggravating the portal hypertensive changes
by performing BRTO has been raised as a major concern
because this procedure requires obliteration of a gastrore-
nal shunt that acts to reduce portal hypertension (16, 28).
Many previous studies concerned with the effects of BRTO
on esophageal varices have demonstrated that it worsens
or develops esophageal varices (8, 10, 11). Thus, it is
important to reveal the effects of BRTO on other portal
hypertensive changes.
CT scans are of considerable value for detecting a variety
of portal hypertensive changes, including ascites,
splenomegaly, the development of deep portosystemic
collaterals, and GB or intestinal wall edemas. In addition,
the CT scans before and after BRTO should be routinely
obtained to evaluate whether or not there is a gastrorenal
shunt through which gastric varix obliteration can be
performed, and also to assess the therapeutic results of
BRTO. Thus, we evaluated whether BRTO aggravates a
variety of portal hypertensive changes by comparing CT
scans. Only the cases with CT scans obtained within one
week before and after BRTO were included in this study in
order to minimize the effects of other factors, such as the
deterioration of liver cirrhosis.
In terms of the concern that BRTO could aggravate
ascites, a small number of studies have reported a very low
incidence of developing ascites, i.e., ascites occurred in 0
10% of the patients after BRTO, but these studies did not
describe how and when they evaluated this ascites (8, 9,
13, 29). Yet in the present study, ascites developed or was
aggravated in 82% (22 of 27 patients) after BRTO, and this
was statistically significant (p = 0.001). Although direct
comparison of results is impossible due to the lack of
information from the previous studies, this discrepancy
may be greatly attributed to the timing for evaluating the
ascites. According to the previous studies on portal
hemodynamics (14 16), the portal venous pressure is
significantly elevated immediately after BRTO and the
elevated portal venous pressure gradually decreases to
baseline in four weeks after BRTO. Because the timing of
the post-procedural CT scans to assess the therapeutic
effects of BRTO has not been standardized, the timing to
evaluate ascites is quite different between institutions, with
a range of 24 hours to four weeks after BRTO. Based on
our results, where the ascites was evaluated on the post-
procedural CT scans obtained within one week after
BRTO, we believe that BRTO can induce aggravation or
the development of ascites in the short term.
On the other hand, improvement of ascites after BRTO
was observed in two patients in the present study. Fukuda
et al. (30) reported two cases of refractory ascites that
were ameliorated after BRTO and they suggested that two
different outcomes (in relation to ascites) could be
expected after BRTO; these were aggravation of the ascites
induced by portal hypertension and the amelioration of
ascites due to elevated serum albumin levels. Still, the
CT Evaluation of Balloon-Occluded Retrograde Transvenous Obliteration Effect for Gastric Variceal Bleeding Treatment
Korean J Radiol 8(6), December 2007 527mechanism by which BRTO influences ascites seems to be
more complex because the serum albumin level was
reduced from 2.1 g/dL to 2.0 g/dL after BRTO in one of
our two patients who showed improvement of ascites. 
It is interesting that BRTO also seems to be able to
induce splenic enlargement in a short time. In the present
study, splenic enlargement  15% was observed in 56%
of the patients (15 of the 27 patients) after BRTO. The
median volumes of the spleens before and after BRTO
were 438.2 cm
3 and 580.8 cm
3, respectively, with a median
change of 21%, which was significant (p < 0.001). Sixteen
patients had splenomegaly before BRTO, when a splenic
volume of greater than 314.5 cm
3 was used to indicate
splenomegaly as in previous studies (31, 32), and in eight
of these 16 patients, the spleen was enlarged after BRTO.
Because destruction of the blood cells is one of the major
functions of the spleen (33), we evaluated the difference in
the splenic function between the patients with and those
without splenic enlargement after BRTO by comparing the
RBC and platelet counts before and after BRTO. We did
not find a significant difference in the changes of the RBC
and platelet counts between the two groups, which may
suggest no association between splenic enlargement after
BRTO and the alteration of splenic function. We presume
that the splenic enlargement in a short time was mainly
attributable to splenic congestion secondary to portal
hypertension, but there was no objective evidence for this. 
BRTO does not seem to induce significant aggravation or
development of GB and intestinal wall edemas. In this
study, development or aggravation of GB edema after
BRTO was found in four (17%) of 23 patients, and
development or aggravation of intestinal wall edema was
found in nine (33%) of 27 patients. However, most
commonly, there was no new development or change of
GB and intestinal wall edemas after BRTO (GB edema:
61%, 14 of 23 patients, intestinal wall edema: 48%, 13 of
27 patients). No statistical differences were observed in the
GB wall thickness or in the number of edematous bowel
segments before and after BRTO.
In addition to portal hypertension, hypoalbuminemia
and ischemia due to hemodynamic instability can be
associated with the short term development or aggravation
of ascites, GB edema and intestinal wall edema (24 27,
34 36). Conversely, resolution or improvement of such
conditions may counteract the effects of BRTO on those
portal hypertensive changes. We have revealed no signifi-
cant association between the changes of the serum albumin
levels and the changes of ascites, GB edema and intestinal
wall edema before and after BRTO. However, this is a
retrospective study, and it cannot evaluate whether or not
ischemia due to hemodynamic instability is associated with
those portal hypertensive changes. This requires compari-
son with the CT scans obtained just before variceal
bleeding, but this is very difficult in practice. Also, indirect
comparison of such hemodynamic parameters as blood
pressures, pulse rates and hemoglobin levels is difficult in
practice because those values are frequently measured in
the patients with variceal bleeding and CT scans following
variceal bleeding are obtained with correction for those
values. 
It is thought that the susceptibility of each organ to the
portal hypertension aggravated by BRTO should also be
considered because some portal hypertensive changes
were aggravated, but others were not in 13 of the 27
patients. On the other hand, some portal hypertensive
changes were aggravated, but others were ameliorated in
eight patients after BRTO. Unfortunately, we cannot
explain these discordant results because this study was
simply designed to compare the CT findings before and
after BRTO.
As was expected, there was no development of new
collateral veins ( 3 mm in the diameter) or enlargement
of the preexisting collaterals ( 2 mm in the diameter)
other than the gastrorenal shunts. According to previous
studies, the development or worsening of collaterals to the
esophageal varices usually occurs one month after BRTO
or even later (8, 11). 
Miyamoto et al. claimed that the elevated portal venous
pressure immediately after BRTO returns to baseline in
four weeks as alternate collaterals develop (15). Those
results can imply that effects of BRTO for elevating the
portal venous pressure would be attenuated with time and
this mostly disappears in four weeks. At the CT follow-up
(range: 1 17 months, median: 2 months) of our 19
patients, six (32%) patients had developed new collateral
veins or there was worsening of the existing collateral
veins (development of a umbilical vein in two and worsen-
ing of the existing coronary or umbilical veins in the other
4). At CT follow-ups of this study, some portal hyperten-
sive changes, including ascites and intestinal wall edema,
were improved or completely resolved in most patients
(ascites: 82%, 14 of 17 patients; intestinal wall edema:
88%, 7 of 8 patients), whereas splenic enlargement
persisted in most patients (73%, 8 of 11 patients).
However, this tendency should be validated in a larger
series because follow-up CT scans were not available for
all the patients of this study. 
The present study has some drawbacks. First, the pre-
and post-procedural CT scans should be obtained at fixed
times to accurately evaluate the effects of BRTO on portal
hypertensive changes, but due to the retrospective nature
of this study, the interval between the pre- and post-
Cho et al.
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not evaluate changes of the clinical signs and symptoms
associated with the portal hypertensive changes after
BRTO. Yet it would seem important to evaluate whether
these portal hypertensive changes after BRTO can cause
clinically significant signs and symptoms.
In conclusion, our findings indicate that some portal
hypertensive changes, including ascites and splenomegaly,
can be aggravated shortly after BRTO, but the mechanisms
involved in this remain a bit obscure. 
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